Fifteen patients, 13 women and 2 men, with a mean age of 72.7 years (56 to 86 years) and a clinical diagnosis of essential voice tremor, were treated with botulinum injections to the thyroarytenoid muscles, and in some cases, to the cricothyroid or thyrohyoid muscles. Evaluations were based on subjective judgments by the patients, and on perceptual and acoustic analysis of voice recordings. Subjective evaluations indicated that the treatment had a beneficial effect in 67% of the patients. Perceptual evaluations showed a significant decrease in voice tremor during connected speech (p < .05). Acoustic analysis showed a nearly significant decrease in the fundamental frequency variations (p = .06) and a significant decrease in fundamental frequency during sustained vowel phonation (p < .01). The results of perceptual evaluation coincided most closely with the subjective judgments. It was concluded that the treatment was successful in 50% to 65% of the patients, depending on the method of evaluation.
AdamsRDVictorM. Principles of neurology. 4th ed. Vol 5. New York, NY: McGraw-Hill, 1989: 78–92.
2.
SmithMOlsonL Ramig. Neurological disorders and the voice. NCVS Status and Progress Report. Vol 7. National Center for Voice and Speech, USA, 1994: 207–27.
AronsonAE. Clinical voice disorders. 3rd ed. New York, NY: Thieme, 1990.
7.
BrinMFFahnSBlitzerAOlsonL RamigStewartC. Movement disorders of the larynx. In: BlitzerABrinMFSasakiCFahnSHarrisK, eds. Neurologic disorders of the larynx. New York, NY: Thieme, 1992: 248–78.
8.
StewartCWinfieldLHuntA. Speech dysfunction in early Parkinson's disease. Mov Disord1995; 10: 562–5.
9.
BlitzerABrinMFFahnS. Clinical and laboratory characteristics of focal laryngeal dystonia. Study of 110 cases. Laryngoscope1988; 98: 636–40.
10.
SchaeferSD. Neuropathology of spasmodic dysphonia. Laryngoscope1983; 93: 1183–204.
11.
MurrayTJ. Essential tremor. Can Med Assoc J1981; 24: 1559–70.
KollerWCBusenbarkKMinerK. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential tremor study group. Ann Neurol1994; 35: 717–23.
14.
ColebatchJGFindleyLJFrackowiakRSMarsdenCDBrooksDJ. Preliminary report: activation of the cerebellum in essential tremor. Lancet1990; 336: 1028–30.
15.
JenkinsIHBainPGColebatchJG. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol1993; 34: 82–90.
16.
AronsonAEHartmanDE. Adductor spasmodic dysphonia as a sign of essential voice tremor. J Speech Hear Disord1981; 46: 52–8.
OlsonL RamigShippT. Comparative measures of vocal tremor and vocal vibrato. J Voice1987; 1: 162–7.
19.
MasseyEWPaulsonGW. Essential vocal tremor: clinical characteristics and response to therapy. South Med J1985; 78: 316–7.
20.
HiroseHImaizumiSYamoriM. Voice quality in patients with neurological disorders. In: FujimuraOHiranoM, eds. Vocal fold physiology: voice quality control. San Diego, Calif: Singular Publishing Group, 1995: 235–48.
21.
LindestadPHertegårdSYlitaloR. Effects of botulinum toxin treatment for adductor spasmodic dysphonia on voice and social function. Logop Phoniatr Vocol1997; 22: 129–34.
22.
HiranoMOhalaJ. Use of hooked-wire electrodes for electromyography of the intrinsic laryngeal muscles. J Speech Hear Res1969; 12: 362–73.
23.
KreimanJGerrattBRKempsterGBErmanABerkeGS. Perceptual evaluation of voice quality: review, tutorial, and a framework for future research. J Speech Hear Res1993; 36: 21–40.
24.
TernströmS. Soundswell — Signal workstation software. Manual [Computer program]. 3.06. Stockholm, Sweden: Soundswell Music Acoustics HB, 1992.
25.
GranqvistS. Corr. Custom-made program [Computer program]. Stockholm, Sweden: Royal Institute of Technology, Department of Speech, Music and Hearing, 1997.
26.
GranqvistS. Extract. Custom-made program [Computer program]. Stockholm, Sweden: Royal Institute of Technology, Department of Speech, Music and Hearing, 1997.
27.
KollerWCGranerDMlcochA. Essential voice tremor: treatment with propranolol. Neurology1985; 35: 106–8.
28.
HartmanDEVishwanatB. Spastic dysphonia and essential voice tremor treated with primidone. Arch Otolaryngol1984; 110: 394–7.
BrinMFBlitzerAStewartCFahnS. Treatment of spasmodic dysphonia (laryngeal dystonia) with local injections of botulinum toxin: review and technical aspects In: BlitzerABrinMFSasakiCFahnSHarrisK, eds. Neurologic disorders of the larynx. New York, NY: Thieme, 1992: 214–28.
31.
TomodaHShibasakiHKurodaYShinT. Dysregulation of voluntary expiratory muscles. Neurology1987; 37: 117–22.
32.
KodaJLudlowCL. An evaluation of laryngeal muscle activation in patients with voice tremor. Otolaryngol Head Neck Surg1992; 107: 684–96.
33.
KrookMI Pegoraro. Speaking fundamental frequency characteristics of normal Swedish subjects obtained by glottal frequency analysis. Folia Phoniatr (Basel)1988; 40: 82–90.
34.
WinholtzWSOlsonL Ramig. Vocal tremor analysis with the vocal demodulator. J Speech Hear Res1992; 35: 562–73.
35.
HiranoMHibiSRHaginoS. Physiological aspects of vibrato. In: DejonckerePHHiranoMSundbergJ, eds. Vibrato. San Diego, Calif: Singular Publishing Group, 1995: 9–34.
36.
TitzeIRSolomonNPLuscheiES. Interference between normal vibrato and artificial stimulation of laryngeal muscles at near-vibrato rates. Voice1994; 8: 215–23.
